In response to the COVID-19 pandemic, the U.S. Government is supporting a national Expanded Access Program to collect and provide convalescent plasma to patients in need across the country (uscovidplasma.org). Convalescent plasma refers to blood plasma collected from people who have recovered from COVID-19. That plasma, which contains antibodies against the virus, is then used to treat others with advanced illness. Working collaboratively with industry, academic and government partners, Mayo Clinic is serving as the lead institution for the program.
On the Mayo Clinic Q&A podcast, Dr. Philippe Bauer, site principal investigator for Mayo Clinic in Rochester, discusses the COVID-19 convalescent plasma program.
To practice safe social distancing during the COVID-19 pandemic, this interview was conducted using video conferencing. The sound and video quality are representative of the technology used.
Connect with others talking about the pandemic and supporting one another in the COVID-19 support group.